These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16525635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells.
    Bertagnolo V, Benedusi M, Brugnoli F, Lanuti P, Marchisio M, Querzoli P, Capitani S.
    Carcinogenesis; 2007 Aug; 28(8):1638-45. PubMed ID: 17429106
    [Abstract] [Full Text] [Related]

  • 3. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P, Alm P, Olsson H, Heidebrecht HJ, Fernö M, Baldetorp B, Parwaresch R.
    Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
    [Abstract] [Full Text] [Related]

  • 4. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer.
    Linder N, Lundin J, Isola J, Lundin M, Raivio KO, Joensuu H.
    Clin Cancer Res; 2005 Jun 15; 11(12):4372-81. PubMed ID: 15958620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K.
    Clin Cancer Res; 2006 Feb 15; 12(4):1201-7. PubMed ID: 16489074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE, Athanassiadou SE, Kamina S, Carassavoglou K, Agnantis NJ.
    Anticancer Res; 1998 Feb 15; 18(3A):1665-70. PubMed ID: 9673387
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
    Meng J, Lang RG, Fan Y, Fu L.
    Zhonghua Zhong Liu Za Zhi; 2007 Apr 15; 29(4):284-8. PubMed ID: 17760256
    [Abstract] [Full Text] [Related]

  • 14. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, Wesseling J.
    Histopathology; 2007 Sep 15; 51(3):322-35. PubMed ID: 17645748
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 15; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 18. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
    Mulligan AM, O'Malley FP, Ennis M, Fantus IG, Goodwin PJ.
    Breast Cancer Res Treat; 2007 Nov 15; 106(1):39-47. PubMed ID: 17221153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.